MOUNTAIN VIEW Calif., Oct. 12, 2012 – Inscopix, Inc. and SRI International today announced a collaborative neuroscience imaging R&D program. Researchers from Inscopix and SRI’s Center for Neuroscience and Metabolic Diseases will use Inscopix’s nVista™ HD imaging system to gain a better understanding of normal brain function and the dysfunctions of neural circuitry that underlie
Unbounded creativity—and powerful computers—make possible the latest devices designed to peer into the deepest recesses of organs and cells. Photography has come a long way in the two decades since digital cameras all but relegated picture taking on film to a chapter in the history book of technology. Image-processing tools like Photoshop and mobile apps
The neurotechnology industry—comprising devices, diagnostics, and drugs targeting the brain and the rest of the nervous system—grew 5.6% in 2011 to $158.6 billion in revenues, reports market research firm NeuroInsights. That growth was evident at the 2012 Society for Neuroscience annual meeting (October 13–17; New Orleans, LA), where a number of companies announced interesting new
